| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 08/20/2013 | CA2557061C Factor ixa for the treatment of bleeding disorders |
| 08/20/2013 | CA2545219C Efficient introduction of an aerosol into a ventilator circuit |
| 08/20/2013 | CA2504953C A new target for angiogenesis and anti-angiogenesis therapy |
| 08/20/2013 | CA2492333C Canine respiratory coronavirus (crcv) spike protein, polymerase and hemagglutinin/esterase |
| 08/20/2013 | CA2488558C Prevention and reduction of blood loss |
| 08/20/2013 | CA2477794C System and method for the production of recombinant glycosylated proteins in a prokaryotic host |
| 08/20/2013 | CA2452417C Compositions comprising the biologicially active peptide ysl |
| 08/20/2013 | CA2440358C Denaturant stable and/or protease resistant, chaperone-like oligomeric proteins, polynucleotides encoding same and their uses |
| 08/20/2013 | CA2398723C Pharmaceutical composition comprising carriers for products based on vitamin-e, papain and hyaluronidase |
| 08/15/2013 | WO2013120073A1 Synthetic toll-like receptor-4 (tlr-4) agonist peptides |
| 08/15/2013 | WO2013120060A1 Delivery of therapeutic agents by a collagen binding protein |
| 08/15/2013 | WO2013120058A2 Novel sp-b & sp-c peptides, synthetic lung surfactants, and use thereof |
| 08/15/2013 | WO2013120022A2 Treatment of hypoglycemia |
| 08/15/2013 | WO2013119923A1 Different states of cancer stem cells |
| 08/15/2013 | WO2013119877A1 Virion-derived nanospheres for selective delivery of therapeutic and diagnostic agents to cancer cells |
| 08/15/2013 | WO2013119870A1 Compositions and methods for treatment of peripheral vascular disease |
| 08/15/2013 | WO2013119863A1 Timothy grass allergens and methods and uses for immune response modulation |
| 08/15/2013 | WO2013119825A1 Modulators of tousled kinase in cellular processes |
| 08/15/2013 | WO2013119821A1 Class i and ii lantibiotics from geobacillus thermodenitrificans |
| 08/15/2013 | WO2013119715A1 Determination of immunogenic peptides in lysosomal enzymes and induction of oral tolerance |
| 08/15/2013 | WO2013119668A1 Mucins as antiviral compounds |
| 08/15/2013 | WO2013119650A1 Delivery of biotherapeutics to the brain |
| 08/15/2013 | WO2013119170A2 Prevention of inflammatory disorders in domestic non-human mammals |
| 08/15/2013 | WO2013119042A1 Composition for preventing or curing neuropathic pain comprising substance-p |
| 08/15/2013 | WO2013118165A1 Pharmaceutical agents fused with atf for improved bioavailability |
| 08/15/2013 | WO2013118128A2 Cellular apobec3 proteins and modulators thereof for regulating dna repair processes |
| 08/15/2013 | WO2013118093A1 Therapeutic method of treatment for inhibiting tumor development using tamm-horsfall glycoprotein (thp) as immunostimulating drug and compositions |
| 08/15/2013 | WO2013118033A1 NOVEL BINDING SITE OF ΙΚΚ-β |
| 08/15/2013 | WO2013117729A1 Use of beta-nerve growth factor for inducing ovulation in mammals |
| 08/15/2013 | WO2013117581A1 Metabolically stable variants of chemerin 9 |
| 08/15/2013 | WO2013116903A1 Methods for the characterisation of interaction sites on target proteins |
| 08/15/2013 | WO2013094992A3 Use of growth factor for regenerating damaged periodontal tissue and pulp tissue of extracted tooth, composition containing said growth factor as active ingredient, and kit for tissue regeneration |
| 08/15/2013 | WO2013093514A3 Vaccines - peptides |
| 08/15/2013 | WO2013093489A3 Detection and treatment of breast cancer |
| 08/15/2013 | WO2013078250A3 Cystine knot peptides that bind alpha-v-beta-6 integrin |
| 08/15/2013 | WO2013074816A3 Novel inhibitors of nox1 |
| 08/15/2013 | WO2013066438A3 Evaluation and improvement of nuclease cleavage specificity |
| 08/15/2013 | WO2013006486A9 Compositions, uses and methods for treatment of metabolic disorders and diseases |
| 08/15/2013 | WO2012170969A3 Pro-coagulant compounds and methods of use thereof |
| 08/15/2013 | US20130212740 Fucosyl transferase gene |
| 08/15/2013 | US20130211368 Microfabricated nanopore device for sustained release of therapeutic agent |
| 08/15/2013 | US20130210898 Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same |
| 08/15/2013 | US20130210778 Formulation for the prevention of cardiovascular disease |
| 08/15/2013 | US20130210746 Pharmaceutical composition |
| 08/15/2013 | US20130210740 Neo-tryptophan |
| 08/15/2013 | US20130210739 Bhlh proteins and their use as drugs |
| 08/15/2013 | US20130210738 Composition for preventing and treating neurological diseases comprising osmotin |
| 08/15/2013 | US20130210737 Biopolymer Produced By Fermenting the Extract of Soybean with Folic Acid and a Composition Containing Thereof |
| 08/15/2013 | US20130210735 Emd formulation comprising pga |
| 08/15/2013 | US20130210734 Method of preventing progression of hypertension-induced heart failure with pkc peptides |
| 08/15/2013 | US20130210733 Methods of treating lung disease |
| 08/15/2013 | US20130210732 Agent for reducing risk in onset of disease ascribable to non-dipper circadian rhythm of blood pressure |
| 08/15/2013 | US20130210731 Compositions and methods to control angiogenesis with cupredoxins |
| 08/15/2013 | US20130210730 Method of treating dyspnea associated with acute heart failure |
| 08/15/2013 | US20130210728 Topical ophthalmic peptide formulation |
| 08/15/2013 | US20130210727 Stabilization of fsh |
| 08/15/2013 | US20130210726 Compositions and methods for treatment of peripheral vascular disease |
| 08/15/2013 | US20130210725 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130210723 Use of the Insulin-Like-Growth Factor 1 Splice Variant MGF for the Prevention of Myocardial Damage |
| 08/15/2013 | US20130210722 Methods for using peptide agonists having glp-1 activity |
| 08/15/2013 | US20130210717 Gene therapy for diabetes with chitosan-delivered plasmid encoding glucagon-like peptide 1 |
| 08/15/2013 | US20130210710 Treatment of hiv |
| 08/15/2013 | US20130210708 Methods of inhibiting and treating bacterial biofilms by metal chelators |
| 08/15/2013 | US20130210135 Recombinant vsv for the treatment of tumor cells |
| 08/15/2013 | US20130210116 Composition and methods for the diagnosis and treatment of tumor |
| 08/15/2013 | US20130210076 Conditioned cell culture medium compositions and methods of use |
| 08/15/2013 | US20130209586 Prevention And Treatment Of Cardiac Arrhythmias |
| 08/15/2013 | US20130209580 Method for treating alzheimer's disease |
| 08/15/2013 | US20130209568 Biodegradable phase separated segmented multi block co-polymers and release of biologically active polypeptides |
| 08/15/2013 | US20130209566 Nanoparticle composition and methods to make and use the same |
| 08/15/2013 | US20130209551 Pentapeptide derivatives for promoting hair growth |
| 08/15/2013 | US20130209549 Materials and methods for treating neurodegenerative diseases |
| 08/15/2013 | US20130209546 Combinatorial methods and compositions for treatment of melanoma |
| 08/15/2013 | US20130209545 Topical therapeutic formulations |
| 08/15/2013 | US20130209522 Drug Release from a Polymer-Controlled Local Antibiotic Delivery System Using a Degradable Bone Graft |
| 08/15/2013 | US20130209518 Combinations and modes of administration of therapeutic agents and combination therapy |
| 08/15/2013 | US20130209490 Diagnostic BioMarkers for Fibrotic Disorders |
| 08/15/2013 | US20130209488 Methods and compositions for malic enzyme 2 (me2) as a target for cancer therapy |
| 08/15/2013 | US20130209487 Treatment of Avian Species with Inhibitors of P110 Delta Signaling |
| 08/15/2013 | US20130209485 Therapeutic agent of non-allergic airway inflammation and/or non-allergic hyperresponsive airway |
| 08/15/2013 | US20130209474 Wise/sost nucleic acid sequences and amino acid sequences |
| 08/15/2013 | US20130209467 Method of treating fibroproliferative disorders |
| 08/15/2013 | US20130209464 Polypeptides having antiviral activity and methods for use thereof |
| 08/15/2013 | US20130209459 TREATMENT WITH ANTI-ErbB2 ANTIBODIES |
| 08/15/2013 | US20130209450 Compositions and Methods for Treating Glioblastoma GBM |
| 08/15/2013 | US20130209443 Method for Treating Oncological Diseases |
| 08/15/2013 | US20130209442 Wound cleaning chemical composition and method for manufacturing |
| 08/15/2013 | US20130209441 Process for inhibition of cerebral damage associated with ischemia by anthocyanins and anthocyanidins |
| 08/15/2013 | US20130209440 Methods and compositions for the treatment of insulin-associated medical conditions |
| 08/15/2013 | US20130209438 Prostatic Acid Phosphatase for the Treatment of Pain |
| 08/15/2013 | US20130209436 Lysosomal storage disease enzymes |
| 08/15/2013 | US20130209432 Product and process for liquefaction of mucus or sputum |
| 08/15/2013 | US20130209425 Encapsulation of pancreatic cells derived from human pluripotent stem cells |
| 08/15/2013 | US20130209419 Methods of Engraftment |
| 08/15/2013 | US20130209411 Lactocepins For Use in the Treatment of IP-10-Mediated Inflammatory Diseases |
| 08/15/2013 | US20130209410 Expression vector for cholesterol 24 -hydrolase in therapy of huntington's disease |
| 08/15/2013 | US20130209408 Bacteriophage-containing therapeutic agents |
| 08/15/2013 | US20130209401 Compositions and methods for inhibiting entry of a hepatic virus |
| 08/15/2013 | US20130209399 Anti-virus therapy for respiratory diseases |
| 08/15/2013 | US20130209398 Conditioned cell culture medium compositions and methods of use |